Are Novo Nordisk and Ozempic Saving the Economy?

Photo by Nappy on Unsplash

In its 2015 Annual Report (and maybe even before) Novo Nordisk already had the goal to see obesity as major focus area and illeness that has to be treated. This was at a point where obesity sales were only responsible for a small fraction of overall sales and Novo Nordisk only had Saxenda in its portfolio. The market was already growing with a high pace but according to Novo Nordisk the total market value…